华润医药(03320.HK) 公布,附属华润博雅生物2024年度业绩,营业总收入17.35亿人民币(下同),按年下降34.6%。股东应占净利润3.97亿元,增长67.2%,每股盈利79分。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2025-03-18 16:25。)过往派息公布日期派息事项派息内容2024/08/29中期业绩股息:人民币 0.0830 (约相等于 0.0908 港元, ...
Source Link华润医药(03320.HK) 公布,附属华润博雅生物2024年度业绩,营业总收入17.35亿人民币(下同),按年下降34.6%。股东应占净利润3.97亿元,增长67.2%,每股盈利79分。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2025-03-18 16:25。)过往派息公布日期派息事项派息内容2024/08/29中期业绩股息:人民币 0.0830 (约相等于 0.0908 港元, ...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.